Rhythm Pharmaceuticals
RYTM
RYTM
227 hedge funds and large institutions have $4.2B invested in Rhythm Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 92 increasing their positions, 74 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
3% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 33
0% more funds holding
Funds holding: 227 → 227 (0)
62% less call options, than puts
Call options by funds: $13.8M | Put options by funds: $36.7M
Holders
227
Holding in Top 10
10
Calls
$13.8M
Puts
$36.7M
Top Buyers
| 1 | +$47.4M | |
| 2 | +$40.4M | |
| 3 | +$32.5M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$21.5M |
| 5 |
ClearBridge Investments
New York
|
+$19.7M |
Top Sellers
| 1 | -$57.5M | |
| 2 | -$37.1M | |
| 3 | -$36M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$33.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$19.1M |
